Is Upstate New York Transplant Services Inc Legit?

Upstate New York Transplant Services Inc demonstrates consistent financial stability and growth over the past decade, with revenues steadily increasing from $24.9 million in 2014 to $37.7 million in 2023. The organization consistently operates with a surplus, as seen in 2023 where revenue was $37,750,254 against expenses of $37,144,770, indicating sound financial management. Their asset base has also grown significantly, from $21.3 million in 2014 to $36.4 million in 2023, providing a strong foundation for future operations. The organization's spending efficiency appears strong, with expenses closely aligned with revenue, suggesting that funds are being utilized for their intended purpose without excessive accumulation or significant deficits (except for a minor deficit in 2022). A notable aspect of their financial health is the reported 0% officer compensation across all available filings, which is highly unusual for an organization of this size and suggests either a unique compensation structure or a high degree of volunteer leadership at the top. This practice, while potentially indicating a commitment to mission, also raises questions about the transparency of leadership compensation if it is being reported under other expense categories. Overall, the organization exhibits good financial health with consistent revenue growth and asset accumulation. The lack of reported officer compensation is a significant factor in assessing transparency, as it deviates from typical nonprofit reporting. Further investigation into how leadership is compensated, if at all, would provide a more complete picture of their financial transparency.